EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

One Month of Brief Weekly Magnetic Field Therapy Enhances the Anticancer Potential of Female Human Sera: Randomized Double-Blind Pilot Study

Jan Nikolas Iversen iD, Yee Kit Tai, Jasmine Lye Yee Yap, Rafhanah Banu Binte Abdul Razar, Viresh Krishnan Sukumar iD, Kwan Yu Wu iD, Melissa Gaik-Ming Ooi iD, Marek Kukumberg, Sabrina Adam, Abdul Jalil Rufaihah, Alfredo Franco-Obregón iD

Cells · 23.02.2025 · 14 (5) · 331

DOI: 10.3390/cells14050331 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cells, online erschienen am 23.02.2025. Verfasst von Jan Nikolas Iversen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore. Hauptthemen laut MEDLINE: Magnetic Field Therapy, Breast Neoplasms, Magnetic Fields. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Singapore Therapeutic Development Review (A*STAR), Healthy Longevity Catalyst Award (NMRC), Pulsing Magnetic Field Therapy Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preclinical studies have shown that the blood from female mice exposed weekly to magnetic fields inhibited breast cancer growth. This double-blind randomized controlled trial investigated whether analogous magnetic therapy could produce similar anticancer sera from human subjects. Twenty-six healthy adult females (ages 30–45) were assigned to either a magnetic therapy group, receiving twice weekly 1 mT magnetic exposures (10 min/session) for 4 weeks, or a control group, who underwent identical sham exposure. Blood sera were evaluated for their capacity to modulate breast cancer-related cellular responses and epithelial–mesenchymal transition. The sera from the magnetic therapy group subjects exhibited significant anticancer effects that were strongest one month after the last magnetic exposure, whereas the sera from unexposed females or unexposed or exposed males showed no effect. Female sera from the magnetic therapy group (n = 12) reduced breast cancer cell proliferation (16.1%), migration (11.8%) and invasion (28.2%) and reduced the levels of key EMT markers relative to the control sera (n = 14). Magnetic therapy modulated the serum levels of angiogenic and myogenic biomarkers in a manner consistent with improved cancer management. Muscle-targeted magnetic therapy holds the potential to enhance the anticancer properties of human blood via an adaptive process, akin to exercise training.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Field TherapyBreast NeoplasmsMagnetic FieldsHumansFemalePilot ProjectsDouble-Blind MethodAdultMiddle AgedCell ProliferationEpithelial-Mesenchymal TransitionCell MovementMale

Stichwörter der Autor:innen

angiogenesisbreast cancerepithelial–mesenchymal transitionmetastasisperipheral artery diseasesoluble biomarkers

Autor:innen und Institutionen

  • Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
  • Institute of Health Technology and Innovation (iHealthtech), National University of Singapore, Singapore 117599, Singapore.
  • Biolonic Currents Electromagnetic Pulsing Systems Laboratory (BICEPS), National University of Singapore, Singapore 117599, Singapore.
  • NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.
  • Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
  • Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore.

ORCID-Profile: Jan Nikolas Iversen, Viresh Krishnan Sukumar, Kwan Yu Wu, Melissa Gaik-Ming Ooi, Alfredo Franco-Obregón

Förderung

  • Singapore Therapeutic Development Review (A*STAR)
  • Healthy Longevity Catalyst Award (NMRC)
  • Pulsing Magnetic Field Therapy Research Fund

Zitieren

APA

Iversen, J. N., Tai, Y. K., Yap, J. L. Y., Abdul Razar, R. B. B., Sukumar, V. K., Wu, K. Y., Ooi, M. G., Kukumberg, M., Adam, S., Rufaihah, A. J., & Franco-Obregón, A. (2025). One Month of Brief Weekly Magnetic Field Therapy Enhances the Anticancer Potential of Female Human Sera: Randomized Double-Blind Pilot Study. Cells, 14(5), 331. https://doi.org/10.3390/cells14050331

Vancouver

Iversen JN, Tai YK, Yap JLY, Abdul Razar RBB, Sukumar VK, Wu KY, et al. One Month of Brief Weekly Magnetic Field Therapy Enhances the Anticancer Potential of Female Human Sera: Randomized Double-Blind Pilot Study. Cells. 2025;14(5):331. doi:10.3390/cells14050331

BibTeX
@article{Iversen2025,
  author = {Iversen, Jan Nikolas and Tai, Yee Kit and Yap, Jasmine Lye Yee and Abdul Razar, Rafhanah Banu Binte and Sukumar, Viresh Krishnan and Wu, Kwan Yu and Ooi, Melissa Gaik-Ming and Kukumberg, Marek and Adam, Sabrina and Rufaihah, Abdul Jalil and Franco-Obregón, Alfredo},
  title = {One Month of Brief Weekly Magnetic Field Therapy Enhances the Anticancer Potential of Female Human Sera: Randomized Double-Blind Pilot Study},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {5},
  pages = {331},
  doi = {10.3390/cells14050331}
}
Kostenlos starten →